An evidence-based review of the outcome of fulvestrant plus a targeted agent versus fulvestrant alone in treating hormone receptor-positive endocrine therapy-resistant metastatic breast cancer - Hua, Yu-Ming (Archives of gynecology and obstetrics, 2019)
Keywords: Adult; Antineoplastic Combined Chemotherapy Protocols - pharmacology; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - pathology; Cancer therapies; Disease-Free Survival; Endocrine therapy; Endocrinology; Female; Fulvestrant - pharmacology; Fulvestrant - therapeutic use; Gynecologic Oncology; Gynecology; Human Genetics; Humans; Medicine; Medicine & Public Health; Meta-analysis; Metastasis; Middle Aged; Neoplasm Metastasis; Obstetrics/Perinatology/Midwifery; Treatment Outcome; Endocrine resistance; Targeted agent; Breast cancer; Fulvestrant; Meta-analysis